
  
    
      
        Background
        The 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> locus (MIM *<NUMEX TYPE="CARDINAL">191160</NUMEX>) has been
        <ENAMEX TYPE="ORGANIZATION">associated</ENAMEX> with susceptibility to a wide range of
        infectious and inflammatory diseases, including <ENAMEX TYPE="DISEASE">malaria</ENAMEX>,
        typhoid, leishmaniasis, <ENAMEX TYPE="DISEASE">meningococcal sepsis</ENAMEX>, trachoma,
        <ENAMEX TYPE="DISEASE">asthma</ENAMEX>, <ENAMEX TYPE="DISEASE">multiple sclerosis</ENAMEX>, and inflammatory bowel disease
        [ <NUMEX TYPE="CARDINAL">1 2 3 4 5 6 7 8 9 10 11</NUMEX> ] . Thus far, these associations
        have not been mapped in any detail, and as 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> lies in the central part of the
        major histocompatibility <ENAMEX TYPE="FAC_DESC">complex</ENAMEX> (MHC), there are many
        candidate genes that could potentially be responsible. A
        strong <ENAMEX TYPE="PER_DESC">candidate</ENAMEX> is 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> itself, as it encodes the potent
        pro-inflammatory cytokine <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>, and there is a significant
        <ENAMEX TYPE="PER_DESC">body</ENAMEX> of clinical and experimental data suggesting a causal
        role for it in the pathogenesis of many of the diseases
        with which it has been associated. Furthermore, most of the
        reported <ENAMEX TYPE="ORG_DESC">associations</ENAMEX> are with polymorphisms located in the
        
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> <ENAMEX TYPE="PER_DESC">promoter</ENAMEX> region, and cellular
        studies of gene regulation 
        in vitro suggest that the molecular
        basis of the disease association maybe, at least in some
        cases, a direct effect of the polymorphism on levels of
        gene expression [ <ENAMEX TYPE="LAW">3 12</ENAMEX> ] .
        To pursue the causal origin of these 
        TNF disease <ENAMEX TYPE="ORG_DESC">associations</ENAMEX> we must
        begin with a detailed understanding of the allelic
        associations between different 
        <ENAMEX TYPE="GPE">TNF SNPs</ENAMEX>. This is particularly
        important considering that within <TIMEX TYPE="DATE">a few hundred</TIMEX> base pairs,
        there are several potentially functional polymorphisms
        which show apparently independent disease <ENAMEX TYPE="ORG_DESC">associations</ENAMEX> with
        severe <ENAMEX TYPE="DISEASE">malaria</ENAMEX> [ <NUMEX TYPE="CARDINAL">1 2 3</NUMEX> ] . Alternatively, these 
        <ENAMEX TYPE="ORGANIZATION">TNF SNPs</ENAMEX> may be serving as neutral
        markers of functional <ENAMEX TYPE="PER_DESC">polymorphisms</ENAMEX> elsewhere in the
        <ENAMEX TYPE="ORGANIZATION">central MHC</ENAMEX>. In order to understand, <NUMEX TYPE="ORDINAL">first</NUMEX>, how the 
        TNF SNPs relate to each other, and
        <NUMEX TYPE="ORDINAL">second</NUMEX>, which <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> are the best markers of the 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> locus in general, we applied two
        new analytical techniques to our haplotypic data. The
        first, <ENAMEX TYPE="ORG_DESC">association</ENAMEX> efficiency analysis (AEA), precisely
        defines the ability of <NUMEX TYPE="CARDINAL">one</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> to detect <ENAMEX TYPE="ORG_DESC">association</ENAMEX> at
        every other <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> in a case-control scenario. The <NUMEX TYPE="ORDINAL">second</NUMEX>
        <ENAMEX TYPE="PERSON">technique</ENAMEX>, entropy maximization method (EMM), selects those
        <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> that most effectively dissect the underlying
        haplotypic structure of a locus. The results of these
        analyses allow us to prioritize <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> for genotyping in
        future <ENAMEX TYPE="DISEASE">disease</ENAMEX>-association studies.
      
      
        Results
        
          Haplotyping the TNFlocus
          <NUMEX TYPE="CARDINAL">Twelve</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> spanning <NUMEX TYPE="QUANTITY">4.3 kb</NUMEX> (Figure <NUMEX TYPE="CARDINAL">1</NUMEX>) were genotyped
          in <NUMEX TYPE="CARDINAL">212</NUMEX> <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> and <NUMEX TYPE="CARDINAL">84</NUMEX> <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> <ENAMEX TYPE="PER_DESC">adults</ENAMEX> with no missing
          <ENAMEX TYPE="ORGANIZATION">data</ENAMEX>. Allele frequencies for each <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> are listed in Table
          <NUMEX TYPE="CARDINAL">1</NUMEX>. The <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> genotypic data had <NUMEX TYPE="MONEY">354/2,544</NUMEX> (<NUMEX TYPE="PERCENT">14%</NUMEX>) sites
          where gametic phase was unknown, and the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> data
          had <NUMEX TYPE="MONEY">188/1,008</NUMEX> (<NUMEX TYPE="PERCENT">19%</NUMEX>) <ENAMEX TYPE="FAC_DESC">sites</ENAMEX> where gametic phase was
          unknown. Where available, genotypes from offspring of the
          <ENAMEX TYPE="PER_DESC">adults</ENAMEX> were used to phase these data (using the program
          <ENAMEX TYPE="ORGANIZATION">PHAMILY</ENAMEX>), which reduced the number to <NUMEX TYPE="MONEY">127/2,544</NUMEX> (<NUMEX TYPE="PERCENT">5%</NUMEX>)
          phase-unknown sites in the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> dataset and <NUMEX TYPE="CARDINAL">75/1,008</NUMEX>
          (<NUMEX TYPE="PERCENT">7%</NUMEX>) phase-unknown sites in the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> <ENAMEX TYPE="PER_DESC">dataset</ENAMEX>. The
          <ENAMEX TYPE="ORGANIZATION">data</ENAMEX> were pooled and the program PHASE was then used to
          assign the remaining phase-unknown sites. After inferring
          haplotypes, <NUMEX TYPE="CARDINAL">only 6/2,544</NUMEX> (<NUMEX TYPE="PERCENT">0.2%</NUMEX>) phase assignments were
          less than <NUMEX TYPE="PERCENT">90%</NUMEX> certain in the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> dataset, and only
          <NUMEX TYPE="CARDINAL">2/1,008</NUMEX> (<NUMEX TYPE="PERCENT">0.2%</NUMEX>) phase assignments were <NUMEX TYPE="PERCENT">less than 90%</NUMEX>
          certain in the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> <ENAMEX TYPE="PER_DESC">dataset</ENAMEX>. All other assignments
          (<NUMEX TYPE="CARDINAL">121/2,544 and 73/1,008</NUMEX>) were greater than <NUMEX TYPE="PERCENT">90%</NUMEX> certain.
          These <NUMEX TYPE="CARDINAL">424</NUMEX> <ENAMEX TYPE="NATIONALITY">Gambian</ENAMEX> haplotypes and <NUMEX TYPE="CARDINAL">168</NUMEX> <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> haplotypes
          (<ENAMEX TYPE="PRODUCT">Table 2</ENAMEX>) were the basis of subsequent analyses
          reported.
        
        
          Haplotype distributions in <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="PER_DESC">populations</ENAMEX>
          In the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> sample, we observed <NUMEX TYPE="CARDINAL">24</NUMEX> different
          haplotypes, and the distribution was dominated by one
          major haplotype (<NUMEX TYPE="PERCENT">37.0%</NUMEX>) and <NUMEX TYPE="CARDINAL">two</NUMEX> others (<NUMEX TYPE="PERCENT">16.7%</NUMEX>, <NUMEX TYPE="PERCENT">16.5%</NUMEX>)
          (<ENAMEX TYPE="PRODUCT">Table 2</ENAMEX>, Figure <NUMEX TYPE="CARDINAL">2</NUMEX>). Thirteen haplotypes of low frequency
          made up <NUMEX TYPE="PERCENT">another 28%</NUMEX>, and <NUMEX TYPE="PERCENT">2%</NUMEX> of alleles were singletons
          (<ENAMEX TYPE="NATIONALITY">haplotypes</ENAMEX> observed only once in the sample). The gene
          diversity, or probability that <NUMEX TYPE="CARDINAL">two</NUMEX> haplotypes chosen at
          <ENAMEX TYPE="ORGANIZATION">random</ENAMEX> from the sample are different, was <NUMEX TYPE="MONEY">0.80</NUMEX> (standard
          <ENAMEX TYPE="PERSON">deviation</ENAMEX> (SD) <NUMEX TYPE="MONEY">0.01</NUMEX>). There is one nonrecombinant
          haplotype that is found only in The <ENAMEX TYPE="GPE">Gambia</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">8</ENAMEX>).
          The <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> sample included <NUMEX TYPE="CARDINAL">21</NUMEX> different haplotypes,
          <NUMEX TYPE="CARDINAL">13</NUMEX> of which were shared with the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> population
          (<ENAMEX TYPE="PRODUCT">Table 2</ENAMEX>, Figure <NUMEX TYPE="CARDINAL">2</NUMEX>). The predominant haplotype in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>
          was not as common, at <NUMEX TYPE="PERCENT">25.0%</NUMEX>, and there were <NUMEX TYPE="CARDINAL">three</NUMEX> other
          haplotypes with frequencies <NUMEX TYPE="PERCENT">greater than 10%</NUMEX> (<NUMEX TYPE="PERCENT">23.2%</NUMEX>,
          <NUMEX TYPE="PERCENT">16.1% and 10.1%</NUMEX>). <ENAMEX TYPE="PRODUCT">Haplotype 9</ENAMEX>, bearing the <NUMEX TYPE="ORDINAL">-1031C</NUMEX> and
          -863A <ENAMEX TYPE="PER_DESC">alleles</ENAMEX>, is much more common in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX> than in The
          <ENAMEX TYPE="PERSON">Gambia</ENAMEX>, at <NUMEX TYPE="PERCENT">16.1%</NUMEX> versus <NUMEX TYPE="PERCENT">5.4%</NUMEX>. <NUMEX TYPE="CARDINAL">Four</NUMEX> percent of the
          <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> <ENAMEX TYPE="PER_DESC">alleles</ENAMEX> were present as singletons. The gene
          diversity in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX> was slightly greater at <NUMEX TYPE="MONEY">0.85</NUMEX> (SD
          <NUMEX TYPE="MONEY">0.01</NUMEX>).
          <ENAMEX TYPE="PERSON">Wright</ENAMEX>'s 
          F statistic reveals differences
          between <ENAMEX TYPE="PER_DESC">populations</ENAMEX> by calculating the reduction in
          heterozygosity that is expected after random mating
          between the <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="PER_DESC">populations</ENAMEX>. For the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> and <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX>
          populations the 
          F 
          
            <ENAMEX TYPE="ORGANIZATION">ST</ENAMEX> 
           = <NUMEX TYPE="CARDINAL">0.021</NUMEX>. Permutations of the data under a null
          hypothesis of no differences between the <ENAMEX TYPE="PER_DESC">populations</ENAMEX>
          gives a probability of <NUMEX TYPE="CARDINAL">0.0001</NUMEX>. An exact test of
          <ENAMEX TYPE="PER_DESC">population differentiation</ENAMEX> finds the observed haplotype
          distributions to be a <ENAMEX TYPE="PER_DESC">poor</ENAMEX> fit of a model of random
          mating between the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> and <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> <ENAMEX TYPE="SUBSTANCE">samples</ENAMEX>, with a
          probability <NUMEX TYPE="PERCENT">less than 10 -5</NUMEX>.
        
        
          Recombination
          Results of the <NUMEX TYPE="CARDINAL">four</NUMEX>-gamete test on pairs of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> in
          each <ENAMEX TYPE="PER_DESC">population</ENAMEX> reveal that in The <ENAMEX TYPE="GPE">Gambia</ENAMEX>, <NUMEX TYPE="MONEY">19/66</NUMEX> (<NUMEX TYPE="PERCENT">29%</NUMEX>)
          pairs of loci have all <NUMEX TYPE="CARDINAL">four</NUMEX> possible haplotypes present;
          while in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, <NUMEX TYPE="MONEY">15/55</NUMEX> (<NUMEX TYPE="PERCENT">27%</NUMEX>) pairs of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> have all <NUMEX TYPE="CARDINAL">four</NUMEX>
          haplotypes present (Figure <NUMEX TYPE="CARDINAL">3</NUMEX>). Some <ENAMEX TYPE="PER_DESC">high-frequency</ENAMEX> (and
          presumably older) <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> show evidence of recombination in
          both <ENAMEX TYPE="PER_DESC">populations</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">TNF-3025, TNF-1031</ENAMEX>). In <ENAMEX TYPE="GPE">The Gambia</ENAMEX>, the
          <ENAMEX TYPE="ORGANIZATION">TNF-308 SNP</ENAMEX> shows evidence of recombination with <NUMEX TYPE="CARDINAL">six</NUMEX>
          other <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>. In <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, the TNF-<NUMEX TYPE="CARDINAL">244</NUMEX> shows evidence of
          recombination with many other <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>. Interestingly, the
          <ENAMEX TYPE="SUBSTANCE">TNF-863 SNP</ENAMEX>, of relatively high frequency in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>,
          shows no evidence of recombination with any other <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> in
          the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> sample. <ENAMEX TYPE="PERSON">Recombinant</ENAMEX> haplotypes of frequency
          greater than <NUMEX TYPE="PERCENT">1%</NUMEX> are represented in Figure <NUMEX TYPE="CARDINAL">2with</NUMEX> dotted
          lines. Although the branching structure of the 
          <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> genealogy is similar in both
          <ENAMEX TYPE="PERSON">populations</ENAMEX>, there are unique recombination events that
          have differentiated the <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="SUBSTANCE">samples</ENAMEX> (haplotypes <TIMEX TYPE="DATE">17, 20</TIMEX>
          and <NUMEX TYPE="CARDINAL">26</NUMEX>). In <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, there appear to be more recombinant
          haplotypes of <NUMEX TYPE="PERCENT">greater than 1%</NUMEX> frequency.
        
        
          Linkage disequilibrium
          Consistent with the evidence for recombination,
          linkage disequilibrium is variable across the 
          <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> locus (Figure <NUMEX TYPE="CARDINAL">4c,4</NUMEX>d) and
          generally low. Values of pairwise linkage disequilibrium,
          
          r <NUMEX TYPE="CARDINAL">2</NUMEX>, are different between the two
          <ENAMEX TYPE="PERSON">populations</ENAMEX>, though well correlated ( 
          r = <NUMEX TYPE="CARDINAL">0.83</NUMEX>). In <ENAMEX TYPE="GPE">The Gambia</ENAMEX>, <NUMEX TYPE="PERCENT">80%</NUMEX> of
          <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> pairs have the minor alleles in the repulsion phase,
          while in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, <NUMEX TYPE="PERCENT">65%</NUMEX> of <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> pairs are in the repulsion
          phase. Most of the <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> pairs in the repulsion phase have
          very low linkage disequilibrium ( 
          r <TIMEX TYPE="DATE">2</TIMEX>= <NUMEX TYPE="CARDINAL">0</NUMEX>). There are <NUMEX TYPE="CARDINAL">six</NUMEX> pairs of
          <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> that are in the coupling phase in the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX>
          sample, but are in the repulsion phase in The Gambian
          sample, reversing the allelic <ENAMEX TYPE="ORG_DESC">associations</ENAMEX>. Most of these
          occasions involve the <ENAMEX TYPE="PRODUCT">TNF-244A</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">allele</ENAMEX>, which is found on
          <NUMEX TYPE="CARDINAL">only one</NUMEX> haplotype in the <ENAMEX TYPE="GPE">Gambia</ENAMEX> (in phase with the
          <ENAMEX TYPE="PRODUCT">TNF-3025G</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">allele</ENAMEX>), but on <NUMEX TYPE="CARDINAL">five</NUMEX> different haplotypes in
          <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>.
        
        
          <ENAMEX TYPE="ORGANIZATION">Association</ENAMEX> efficiency analysis
          Using <ENAMEX TYPE="ORGANIZATION">Equation</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">2</ENAMEX>) (see <ENAMEX TYPE="PRODUCT">Materials</ENAMEX> and methods) we
          calculate the apparent relative risk at <NUMEX TYPE="CARDINAL">one</NUMEX> marker given
          a relative risk of <NUMEX TYPE="CARDINAL">10</NUMEX> at <TIMEX TYPE="TIME">a second marker</TIMEX> for all pairs of
          <ENAMEX TYPE="ORGANIZATION">markers</ENAMEX>. As an example, we assign a relative risk of <NUMEX TYPE="CARDINAL">10</NUMEX>
          to the <ENAMEX TYPE="PRODUCT">TNF-376A</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">allele</ENAMEX> (this is the relative risk of the
          A allele compared to the <ENAMEX TYPE="ORGANIZATION">G</ENAMEX> allele) and calculate the
          relative risks at all other <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> in the <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> gene using
          the haplotype frequencies from The <ENAMEX TYPE="GPE">Gambia</ENAMEX> (Figure <NUMEX TYPE="CARDINAL">5</NUMEX>). Log
          
          <NUMEX TYPE="CARDINAL">10</NUMEX> of the relative risk is plotted on
          the 
          <ENAMEX TYPE="ORGANIZATION">y -axis</ENAMEX>, so values above the 
          x -axis correspond to disease risk
          while values below the 
          x -axis correspond to disease
          <ENAMEX TYPE="ORGANIZATION">protection</ENAMEX>. We find that the relative risk varies greatly
          across the <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> gene region. The <NUMEX TYPE="CARDINAL">three</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> that are in
          maximum positive linkage disequilibrium ( 
          D ' = <NUMEX TYPE="CARDINAL">1</NUMEX>) with <ENAMEX TYPE="PRODUCT">TNF-376A</ENAMEX> show
          relative risks of <NUMEX TYPE="MONEY">2.2</NUMEX>, <NUMEX TYPE="CARDINAL">3.3</NUMEX>, and <NUMEX TYPE="CARDINAL">2.2</NUMEX> when <ENAMEX TYPE="PRODUCT">TNF-376A</ENAMEX> gives a
          relative risk of <NUMEX TYPE="CARDINAL">10</NUMEX>. The remaining <NUMEX TYPE="CARDINAL">eight</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> in the TNF
          <ENAMEX TYPE="PERSON">gene</ENAMEX> would have a relative risk between <NUMEX TYPE="CARDINAL">0.8</NUMEX> and <NUMEX TYPE="CARDINAL">0.9</NUMEX> when
          the relative risk at <ENAMEX TYPE="PRODUCT">TNF-376A</ENAMEX> is <NUMEX TYPE="MONEY">10</NUMEX> (Figure <NUMEX TYPE="CARDINAL">4</NUMEX>).
          <ENAMEX TYPE="ORGANIZATION">Data</ENAMEX> for all pairs of markers are given in Figure
          4a,4<ENAMEX TYPE="DISEASE">b. Hypothetical disease</ENAMEX> alleles are given along the 
          x -axis, and <ENAMEX TYPE="ANIMAL">marker alleles</ENAMEX> are
          given on the 
          <ENAMEX TYPE="CONTACT_INFO">y -axis.</ENAMEX> Each <ENAMEX TYPE="FAC_DESC">cell</ENAMEX> indicates the
          apparent relative risk ( 
          R ) of a marker on the 
          <ENAMEX TYPE="ORGANIZATION">y</ENAMEX> -axis when the hypothetical
          <ENAMEX TYPE="DISEASE">disease allele</ENAMEX> indicated on the 
          x -axis has a relative risk of <NUMEX TYPE="CARDINAL">10</NUMEX>.
          Using an arbitrary cutoff of <NUMEX TYPE="CARDINAL">0.5</NUMEX> < 
          R <NUMEX TYPE="MONEY">< 2.0</NUMEX> (indicated by blue
          <ENAMEX TYPE="ORGANIZATION">color</ENAMEX>), some markers perform poorly: for example in The
          <ENAMEX TYPE="PRODUCT">Gambia TNF-308</ENAMEX> can only detect <ENAMEX TYPE="PRODUCT">TNF-3025</ENAMEX> ( 
          R = <NUMEX TYPE="CARDINAL">2.9</NUMEX>). Interestingly, if the
          <ENAMEX TYPE="SUBSTANCE">TNF-308 SNP</ENAMEX> were a disease allele, most of the other SNPs
          in <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> would show a moderate protective effect. <ENAMEX TYPE="CONTACT_INFO">TNF-1031</ENAMEX>
          is good at detecting <ENAMEX TYPE="ORG_DESC">associations</ENAMEX> at <NUMEX TYPE="CARDINAL">seven</NUMEX> other <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>. In
          <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, the pattern of association efficiency is
          different, and generally stronger. Most hypothetical
          <ENAMEX TYPE="ORGANIZATION">disease SNPs</ENAMEX> in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX> would be detectable by other SNPs
          in <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>, with the exception of <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<NUMEX TYPE="CARDINAL">476</NUMEX> and <ENAMEX TYPE="PRODUCT">TNF-1073</ENAMEX> which
          have very low frequency and little prospect of being
          detected by other markers.
        
        
          <ENAMEX TYPE="ORGANIZATION">Association</ENAMEX> efficiency analysis compared to linkage
          disequilibrium
          To illustrate the relationship between the association
          efficiency parameter and measures of linkage
          disequilibrium, we plot the log 
          <NUMEX TYPE="CARDINAL">10</NUMEX> of relative risk for all pairs of
          <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> (when <NUMEX TYPE="CARDINAL">one</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> is assigned a relative risk of <NUMEX TYPE="CARDINAL">10</NUMEX>)
          against 
          r 2(Figure 6a,6b). Above the 
          x -axis, 
          r <TIMEX TYPE="DATE">2appears</TIMEX> to be correlated with
          the association efficiency parameter (correlation
          coefficients of 
          r = <NUMEX TYPE="CARDINAL">0.77</NUMEX> in The <ENAMEX TYPE="GPE">Gambia</ENAMEX>, and 
          r = <NUMEX TYPE="CARDINAL">0.91</NUMEX> in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>). Below the 
          x -axis, where the <ENAMEX TYPE="LAW">marker SNP</ENAMEX> gives
          an apparently protective effect, the correlation is not
          as strong ( 
          r = <NUMEX TYPE="PERCENT">-0.61</NUMEX> in The <ENAMEX TYPE="GPE">Gambia</ENAMEX>, 
          r = <NUMEX TYPE="PERCENT">-0.60</NUMEX> in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>). In this
          situation where minor alleles are in the repulsion phase,
          the values for 
          r 2remain low even when association
          efficiency parameter shows a strong protective
          effect.
          The association efficiency parameter is correlated
          with 
          D , the un-normalized linkage
          disequilibrium parameter (Figure <NUMEX TYPE="CARDINAL">6c,6</NUMEX>d). When the
          absolute value of 
          D is great, the association
          efficiency tends to be high; however, many SNP pairs also
          have high <ENAMEX TYPE="ORG_DESC">association</ENAMEX> efficiency even when the absolute
          value of 
          D is low.
          When we plot the <ENAMEX TYPE="ORG_DESC">association</ENAMEX> efficiency parameter
          against the normalized disequilibrium parameter, 
          D ', we see a strong positive
          <ENAMEX TYPE="CONTACT_INFO">correlation:</ENAMEX> 
          r = <NUMEX TYPE="CARDINAL">0.89</NUMEX> in the <ENAMEX TYPE="GPE">Gambia</ENAMEX> and 
          r = <NUMEX TYPE="CARDINAL">0.91</NUMEX> in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX> (Figure 6e,6f).
          Linkage disequilibrium is necessary to detect
          <ENAMEX TYPE="ORGANIZATION">association</ENAMEX>; however, it is not sufficient. Despite 
          D ' = <NUMEX TYPE="CARDINAL">1.0</NUMEX>, some pairs of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> are
          poor markers of each other, showing relative risks
          between <NUMEX TYPE="CARDINAL">0.5</NUMEX> and <NUMEX TYPE="CARDINAL">2.0</NUMEX> when the linked hypothetical disease
          <ENAMEX TYPE="ORGANIZATION">allele</ENAMEX> gives a relative risk of <NUMEX TYPE="CARDINAL">10</NUMEX>.
        
        
          Entropy maximization method
          <ENAMEX TYPE="ORGANIZATION">Entropy</ENAMEX> ( 
          E ), a measure of haplotypic
          diversity, was calculated for the full <NUMEX TYPE="CARDINAL">12</NUMEX>-SNP haplotypes
          in each <ENAMEX TYPE="PER_DESC">population</ENAMEX> (<ENAMEX TYPE="PERSON">Equation</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">4</ENAMEX>) in <ENAMEX TYPE="PRODUCT">Materials</ENAMEX> and
          methods). In the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> sample, 
          E = <NUMEX TYPE="CARDINAL">2.95</NUMEX>; in the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> sample, 
          E = <NUMEX TYPE="CARDINAL">3.23</NUMEX>. To determine if a subset
          of these <NUMEX TYPE="CARDINAL">12</NUMEX> SNPs could account for most of the haplotypic
          diversity in these <ENAMEX TYPE="SUBSTANCE">samples</ENAMEX>, we calculated entropy for all
          possible <ENAMEX TYPE="PER_DESC">subsets</ENAMEX> of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>, increasing the number of SNPs
          in a subset from <TIMEX TYPE="DATE">1 to 12</TIMEX>. In Figure <NUMEX TYPE="QUANTITY">7we</NUMEX> plot the subsets
          of markers with maximum entropy. We begin with a single
          <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX>, and with each additional <ENAMEX TYPE="SUBSTANCE">SNP</ENAMEX> we include, the entropy
          increases. The entropy plateaus when the additional
          markers contribute little additional information. To
          account for <NUMEX TYPE="PERCENT">95%</NUMEX> of the haplotypic diversity of 
          <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> , one must genotype <NUMEX TYPE="CARDINAL">8</NUMEX> of <NUMEX TYPE="CARDINAL">12</NUMEX>
          <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> in <ENAMEX TYPE="GPE">The Gambian</ENAMEX> sample (in order of decreasing
          <ENAMEX TYPE="ORGANIZATION">informativeness</ENAMEX>): <ENAMEX TYPE="CONTACT_INFO">-3025, -308, 851, -1031, -857, 467,</ENAMEX>
          -<NUMEX TYPE="CARDINAL">244</NUMEX>, <NUMEX TYPE="PERCENT">-238</NUMEX>; and type <NUMEX TYPE="CARDINAL">7</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> in the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> sample:
          <ENAMEX TYPE="CONTACT_INFO">-3025, -1031, 851, -308, 1304, -244, -1073</ENAMEX>.
        
      
      
        Discussion
        The 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> locus has been associated with
        <ENAMEX TYPE="ORGANIZATION">susceptibility</ENAMEX> to a wide range of infectious and
        <ENAMEX TYPE="DISEASE">inflammatory diseases</ENAMEX>. In <ENAMEX TYPE="NATIONALITY">African</ENAMEX> <ENAMEX TYPE="PER_DESC">populations</ENAMEX>, three 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> <ENAMEX TYPE="PER_DESC">promoter SNPs</ENAMEX> have been
        independently associated with severe <ENAMEX TYPE="DISEASE">malaria</ENAMEX> [ <NUMEX TYPE="CARDINAL">1 2 3</NUMEX> ] . To
        better understand these complex genetic <ENAMEX TYPE="ORG_DESC">associations</ENAMEX> with
        <ENAMEX TYPE="DISEASE">malaria</ENAMEX>, we have defined the haplotypic structure of the 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> gene region using <NUMEX TYPE="CARDINAL">12</NUMEX> SNPs
        <ENAMEX TYPE="ORGANIZATION">genotyped</ENAMEX> in <NUMEX TYPE="CARDINAL">212</NUMEX> <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> and <NUMEX TYPE="CARDINAL">84</NUMEX> <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> <ENAMEX TYPE="PER_DESC">adults</ENAMEX>. Gametic
        phase was determined by genotyping one <ENAMEX TYPE="PER_DESC">offspring</ENAMEX> from each
        <ENAMEX TYPE="PERSON">adult</ENAMEX> (when available), reducing the number of
        phase-unknown sites by <NUMEX TYPE="PERCENT">65%</NUMEX>. The gametic phase of the
        remaining sites was determined by statistical inference.
        This integration of family- and <ENAMEX TYPE="PER_DESC">population</ENAMEX>-based methods of
        haplotype reconstruction resulted in phase assignments of
        high certainty. This description of the pattern of DNA
        sequence variation provides insight into the genetic
        differentiation of these <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="NATIONALITY">African</ENAMEX> <ENAMEX TYPE="PER_DESC">populations</ENAMEX>, the
        evolution of the <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> gene itself, and the suitability of
        these <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> to serve as markers of disease <ENAMEX TYPE="ORG_DESC">association</ENAMEX>.
        There are a number of interesting features that
        distinguish these <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="PER_DESC">populations</ENAMEX> at the haplotypic level.
        <NUMEX TYPE="CARDINAL">Eleven</NUMEX> <ENAMEX TYPE="PER_DESC">haplotypes</ENAMEX> are unique to the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> sample, and
        <NUMEX TYPE="CARDINAL">eight</NUMEX> are unique to the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> sample. The haplotype
        bearing the <ENAMEX TYPE="PRODUCT">TNF-857T</ENAMEX> <ENAMEX TYPE="PRODUCT_DESC">allele</ENAMEX> was not found in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX> (this
        site is not polymorphic in the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> sample), whereas it
        has a frequency of <NUMEX TYPE="PERCENT">5.2%</NUMEX> in The <ENAMEX TYPE="GPE">Gambia</ENAMEX>. When population
        <ENAMEX TYPE="ORGANIZATION">differentiation</ENAMEX> is assessed by haplotype instead of by
        <ENAMEX TYPE="ORGANIZATION">individual SNP</ENAMEX> frequencies, we observe a greater value for
        <ENAMEX TYPE="PERSON">Wright</ENAMEX>'s fixation index, 
        F 
        
          <ENAMEX TYPE="ORGANIZATION">ST</ENAMEX> 
         = <NUMEX TYPE="CARDINAL">0.021</NUMEX>, compared to 
        F 
        
          <ENAMEX TYPE="ORGANIZATION">ST</ENAMEX> 
         = <NUMEX TYPE="CARDINAL">0.007</NUMEX> for individual <ENAMEX TYPE="ORGANIZATION">TNF SNPs</ENAMEX> [ <TIMEX TYPE="DATE">13</TIMEX> ] . Intragenic
        <ENAMEX TYPE="PERSON">recombination</ENAMEX> seems to have had an important role in
        diversifying the locus and in distinguishing the two
        <ENAMEX TYPE="PERSON">populations</ENAMEX>, as evidenced by a number of
        <ENAMEX TYPE="ORGANIZATION">population</ENAMEX>-specific recombinant haplotypes (<NUMEX TYPE="CARDINAL">7</NUMEX>, <TIMEX TYPE="DATE">17, 20</TIMEX> and
        <NUMEX TYPE="CARDINAL">26</NUMEX>). In spite of the significant differences in haplotype
        distributions between the <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="NATIONALITY">African</ENAMEX> <ENAMEX TYPE="PER_DESC">populations</ENAMEX>, it
        appears that most of the haplotypes have evolved over a
        period of time during which there was gene flow between the
        <NUMEX TYPE="CARDINAL">two</NUMEX> sampled <ENAMEX TYPE="PER_DESC">populations</ENAMEX>. That is, the basic branching
        structure of the gene genealogy is the same in both
        <ENAMEX TYPE="PERSON">populations</ENAMEX>, although frequencies are different and there
        appear to be population specific recombination events
        (Figure <NUMEX TYPE="CARDINAL">2</NUMEX>).
        Our results have some similarities with a report of
        haplotype <ENAMEX TYPE="FAC_DESC">structure</ENAMEX> across <NUMEX TYPE="MONEY">13 megabases</NUMEX> (<ENAMEX TYPE="PRODUCT">Mb</ENAMEX>) in a sample of
        <ENAMEX TYPE="ORGANIZATION">Yorubans</ENAMEX> and <ENAMEX TYPE="NATIONALITY">African-Americans</ENAMEX> [ <TIMEX TYPE="DATE">14</TIMEX> ] . In a haplotype
        <ENAMEX TYPE="ORGANIZATION">block</ENAMEX> defined by <NUMEX TYPE="CARDINAL">12</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>, <NUMEX TYPE="CARDINAL">four</NUMEX> haplotypes <NUMEX TYPE="PERCENT">greater than 5%</NUMEX>
        frequency were found; we find <NUMEX TYPE="CARDINAL">five</NUMEX> in the <ENAMEX TYPE="GPE">Gambia</ENAMEX>, and <NUMEX TYPE="CARDINAL">four</NUMEX>
        in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX> with frequency <NUMEX TYPE="PERCENT">greater than 5%</NUMEX>. However, we find
        that a minimum of <NUMEX TYPE="CARDINAL">8 and 10</NUMEX> haplotypes make up <NUMEX TYPE="PERCENT">90%</NUMEX> of the
        sample in The <ENAMEX TYPE="GPE">Gambia</ENAMEX> and <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, respectively, while they
        report an average minimum of <NUMEX TYPE="CARDINAL">5</NUMEX> haplotypes. Furthermore,
        they report values for 
        D ' that are constant across a
        haplotype block, while we find variability in linkage
        disequilibrium, even over short distances. Our data are
        more consistent with previous reports of haplotypic
        structure where <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> were ascertained by resequencing in a
        large sample of chromosomes [ <NUMEX TYPE="CARDINAL">15 16 17</NUMEX> ] .
        The increased frequency of haplotype <NUMEX TYPE="CARDINAL">1</NUMEX> in the Gambian
        sample has a profound impact on the allelic <ENAMEX TYPE="ORGANIZATION">associations</ENAMEX>
        between <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> as evaluated by <NUMEX TYPE="QUANTITY">chi-square</NUMEX> test or as defined
        by the <ENAMEX TYPE="ORG_DESC">pairwise association</ENAMEX> efficiency parameter. The
        'star-shaped' genealogy of the Gambian 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> locus, dominated by one central
        haplotype with many derived haplotypes defined by single
        mutational events, produces negative disequilibria between
        most pairs of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> (the rare <ENAMEX TYPE="ANIMAL">alleles</ENAMEX> are found in the
        <ENAMEX TYPE="ORGANIZATION">repulsion</ENAMEX> phase). The <NUMEX TYPE="QUANTITY">chi-square</NUMEX> test has low power to
        detect negative disequilibria [ <TIMEX TYPE="DATE">18</TIMEX> ] ; this may explain why
        in the case where 
        <ENAMEX TYPE="PRODUCT">p > 0.05</ENAMEX>, <ENAMEX TYPE="ORGANIZATION">41/42 SNP</ENAMEX> pairs have
        negative disequilibria. The ability of <NUMEX TYPE="CARDINAL">one</NUMEX> marker to detect
        another in a case-control scenario is also greatly reduced
        when <ENAMEX TYPE="PER_DESC">alleles</ENAMEX> are in the repulsion phase. For example, in
        the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> sample, allele pairs in the repulsion phase are
        much more likely to be inefficient markers (where
        inefficient means the apparent relative risk at the marker
        <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> is betwen <NUMEX TYPE="CARDINAL">0.5</NUMEX> and <NUMEX TYPE="CARDINAL">2.0</NUMEX> when the relative risk of the
        <ENAMEX TYPE="DISEASE">hypothetical disease</ENAMEX> SNP is <NUMEX TYPE="CARDINAL">10</NUMEX>) than alleles in the
        coupling phase ( 
        <ENAMEX TYPE="CONTACT_INFO">p < 10 -7</ENAMEX>).
        Although linkage disequilibrium between a disease
        susceptibility locus and a <ENAMEX TYPE="SUBSTANCE">marker locus</ENAMEX> is required to
        detect an association with a complex disease, for a fixed
        sample size, it may not be sufficient. Even in the extreme
        case when linkage disequilibrium is at its theoretical
        <ENAMEX TYPE="PERSON">maximum</ENAMEX> ( 
        D ' = <NUMEX TYPE="PERCENT">100%</NUMEX> and no recombination has
        occurred between the <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>), the relative risk at the
        <ENAMEX TYPE="PERSON">marker</ENAMEX> locus will be some fraction of the relative risk at
        the disease susceptibility locus, unless the <NUMEX TYPE="CARDINAL">two</NUMEX> alleles
        have the same frequency [ <TIMEX TYPE="DATE">19</TIMEX> ] . Using the relationship
        defined in <ENAMEX TYPE="FAC">Equation 2</ENAMEX> (see <ENAMEX TYPE="PRODUCT">Materials</ENAMEX> and methods), we can
        examine the haplotypic structure of a candidate <ENAMEX TYPE="PER_DESC">locus</ENAMEX> and
        assess the ability of <NUMEX TYPE="CARDINAL">one</NUMEX> marker to detect a disease
        <ENAMEX TYPE="ORGANIZATION">association</ENAMEX> when a second marker contributes a given
        disease risk. We calculate <NUMEX TYPE="CARDINAL">two</NUMEX> values of apparent relative
        risk for each pair of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> (assigning each <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> in turn a
        hypothetical risk of <NUMEX TYPE="CARDINAL">10</NUMEX>) and plot them against 
        D ' (Figure <NUMEX TYPE="CARDINAL">6</NUMEX>).
        Pairs of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> where 
        D ' values are reversed between the
        <ENAMEX TYPE="PERSON">populations</ENAMEX> also show a reversal of the relative risk (that
        is, relative risks greater than 1 become less than <NUMEX TYPE="CARDINAL">1</NUMEX>). For
        example, if the risk at <ENAMEX TYPE="ORGANIZATION">SNP TNF</ENAMEX>+<NUMEX TYPE="CARDINAL">851</NUMEX> was <NUMEX TYPE="CARDINAL">10</NUMEX>, then the
        <ENAMEX TYPE="ORGANIZATION">neighboring SNP</ENAMEX>, <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<NUMEX TYPE="CARDINAL">467</NUMEX>, would give a relative risk of <NUMEX TYPE="CARDINAL">3.7</NUMEX>
        in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, but in the <ENAMEX TYPE="NATIONALITY">Gambian</ENAMEX> <ENAMEX TYPE="PER_DESC">population</ENAMEX>, the effect would
        be protective with a relative risk of <NUMEX TYPE="CARDINAL">0.8</NUMEX>. This suggests
        that even with a marker in close physical proximity to a
        <ENAMEX TYPE="ORGANIZATION">disease-susceptibility SNP</ENAMEX>, results may differ greatly and
        even give apparently contradictory results between <NUMEX TYPE="CARDINAL">two</NUMEX>
        <ENAMEX TYPE="PER_DESC">populations</ENAMEX>. This illustrates the importance of identifying
        <ENAMEX TYPE="ORGANIZATION">population</ENAMEX>-specific recombinant chromosomes in the study
        <ENAMEX TYPE="PER_DESC">populations</ENAMEX>. We identify <NUMEX TYPE="CARDINAL">six</NUMEX> pairs of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> that would
        reverse relative risks (that is, reverse the sign of 
        D ) between the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> and <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX>
        <ENAMEX TYPE="PER_DESC">populations</ENAMEX>.
        Although the <ENAMEX TYPE="ORG_DESC">association</ENAMEX> efficiency parameter is
        correlated with 
        D ' ( 
        r = <NUMEX TYPE="CARDINAL">0.99</NUMEX> for combined data), it is
        interesting to consider the situation where 
        D ' = <NUMEX TYPE="CARDINAL">1.00</NUMEX> between the marker and
        <ENAMEX TYPE="DISEASE">hypothetical disease</ENAMEX> SNPs. In this situation, the apparent
        relative risk at a marker <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> may be considerably lower
        than at the <ENAMEX TYPE="DISEASE">disease</ENAMEX> SNP (Figure <NUMEX TYPE="CARDINAL">6</NUMEX>). This is especially
        evident in the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> <ENAMEX TYPE="PER_DESC">population</ENAMEX>. These observations
        suggest that linkage-disequilibrium measures, as summarized
        by 
        D ', may not accurately reflect the
        ability of a marker to detect a disease <ENAMEX TYPE="ORG_DESC">association</ENAMEX>.
        It is troubling to observe that even within a relatively
        small gene like 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> (<NUMEX TYPE="MONEY">4.3 kb</NUMEX> in this study) the SNP
        markers are poorly correlated: if a true
        disease-susceptibility <ENAMEX TYPE="FAC_DESC">allele</ENAMEX> existed in the <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> gene, many
        of the other <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> would be inefficient markers of that
        <ENAMEX TYPE="DISEASE">disease allele</ENAMEX>. Our calculations reveal that even if a
        <ENAMEX TYPE="DISEASE">hypothetical disease</ENAMEX> allele gave a <NUMEX TYPE="CARDINAL">10</NUMEX>-fold increased risk,
        out of the <NUMEX TYPE="CARDINAL">132</NUMEX> possible pairs of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>, in <NUMEX TYPE="CARDINAL">92</NUMEX> of them (<NUMEX TYPE="PERCENT">70%</NUMEX>),
        the marker would show a relative risk of less than twofold.
        Only a small <ENAMEX TYPE="PER_DESC">minority</ENAMEX> of <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> pairs are efficient enough to
        detect a strong disease-modifying <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> in the 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> gene region.
        Although it appears that individual <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> in 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> are poor <ENAMEX TYPE="PER_DESC">markers</ENAMEX> of each other,
        it is important to ask which <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> serve as good markers of
        the 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> haplotypes. Depending on the
        haplotypic structure of a gene region, one may be able to
        choose a small subset of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> that capture most of the
        haplotypic diversity, thus reducing the cost of genotyping
        significantly with only modest reductions in information [
        <NUMEX TYPE="CARDINAL">20 21 22</NUMEX> ] . <NUMEX TYPE="CARDINAL">Two</NUMEX> methods have been reported that select the
        best subset of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> [ <NUMEX TYPE="CARDINAL">20 23</NUMEX> ] . In this paper we introduce
        <NUMEX TYPE="CARDINAL">a third</NUMEX>, the entropy maximization method (EMM), which
        chooses the subset of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> that explains the largest
        proportion of the underlying haplotypic diversity as
        measured by entropy.
        The single <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> with maximum entropy is the <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> with
        frequency closest to <NUMEX TYPE="CARDINAL">0.50</NUMEX>, in this case TNF-<TIMEX TYPE="DATE">3025</TIMEX>. In both
        <ENAMEX TYPE="PERSON">populations</ENAMEX>, this <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> represents <NUMEX TYPE="CARDINAL">about one-third</NUMEX> of the
        haplotypic diversity. With the addition of a <NUMEX TYPE="ORDINAL">second</NUMEX> SNP to
        form a <NUMEX TYPE="CARDINAL">two</NUMEX>-SNP haplotype, <NUMEX TYPE="CARDINAL">one-half</NUMEX> of the haplotypic
        diversity is accounted for. In <ENAMEX TYPE="GPE">The Gambia</ENAMEX>, it is most
        informative to include the <ENAMEX TYPE="PRODUCT">TNF-308 SNP</ENAMEX> as a second marker,
        whereas in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, the <ENAMEX TYPE="PRODUCT">TNF-1031</ENAMEX> SNP contributes the most as
        a <NUMEX TYPE="ORDINAL">second</NUMEX> marker. It is not surprising that <TIMEX TYPE="TIME">the first few</TIMEX>
        <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> selected by the <ENAMEX TYPE="ORGANIZATION">EMM</ENAMEX> are those that have frequencies
        closest to <NUMEX TYPE="CARDINAL">0.50</NUMEX>; however, the addition of a common <ENAMEX TYPE="SUBSTANCE">SNP</ENAMEX> that
        is well correlated with a <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> already in the subset will
        contribute little additional information.
        For example, in the <ENAMEX TYPE="ORGANIZATION">Gambian</ENAMEX> sample, the <NUMEX TYPE="CARDINAL">four</NUMEX> most common
        <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> are selected first by the <ENAMEX TYPE="ORGANIZATION">EMM</ENAMEX> (TNF-<TIMEX TYPE="DATE">3025</TIMEX> (<NUMEX TYPE="PERCENT">38%</NUMEX>), TNF-308
        (<NUMEX TYPE="PERCENT">19%</NUMEX>), <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<NUMEX TYPE="CARDINAL">851</NUMEX> (<NUMEX TYPE="PERCENT">10%</NUMEX>), <ENAMEX TYPE="PRODUCT">TNF-1031</ENAMEX> (<NUMEX TYPE="PERCENT">11%</NUMEX>)). The next most common
        <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> are the <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<TIMEX TYPE="DATE">1304</TIMEX> (<NUMEX TYPE="PERCENT">9%</NUMEX>) and the <ENAMEX TYPE="SUBSTANCE">TNF-863</ENAMEX> (<NUMEX TYPE="PERCENT">6%</NUMEX>); however,
        the <ENAMEX TYPE="ORGANIZATION">EMM</ENAMEX> does not choose these <ENAMEX TYPE="SUBSTANCE">SNPs</ENAMEX> next because the
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<TIMEX TYPE="DATE">1304</TIMEX> tends to occur in phase with the <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<NUMEX TYPE="CARDINAL">851</NUMEX>, and the
        <ENAMEX TYPE="SUBSTANCE">TNF-863</ENAMEX> tends to occur in phase with the <ENAMEX TYPE="PRODUCT">TNF-1031</ENAMEX>, both of
        which are already in the subset of <NUMEX TYPE="CARDINAL">four</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>. So the next
        <NUMEX TYPE="CARDINAL">two</NUMEX> choices that maximize <ENAMEX TYPE="PER_DESC">entropy</ENAMEX> are the <ENAMEX TYPE="SUBSTANCE">TNF-857</ENAMEX> and
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<NUMEX TYPE="CARDINAL">467</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>, which, although less common, represent
        <ENAMEX TYPE="ORGANIZATION">haplotypes</ENAMEX> previously unaccounted for (<NUMEX TYPE="CARDINAL">5 and 8</NUMEX>). These
        <NUMEX TYPE="CARDINAL">six</NUMEX>-SNP haplotypes now represent <NUMEX TYPE="PERCENT">about 90%</NUMEX> of the
        haplotypic diversity. Two more <ENAMEX TYPE="SUBSTANCE">SNPs</ENAMEX> must be added (for a
        total of <NUMEX TYPE="CARDINAL">eight</NUMEX>) before <NUMEX TYPE="PERCENT">95%</NUMEX> of the <NUMEX TYPE="CARDINAL">12</NUMEX>-SNP haplotypic
        diversity is accounted for.
        In <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>, the general features of <ENAMEX TYPE="SUBSTANCE">marker</ENAMEX> selection are
        the same, though the optimal SNPs are different. <NUMEX TYPE="CARDINAL">Three</NUMEX> of
        the <NUMEX TYPE="CARDINAL">four</NUMEX> most common <ENAMEX TYPE="SUBSTANCE">SNPs</ENAMEX> are selected first by the EMM
        (<ENAMEX TYPE="PRODUCT">TNF-3025</ENAMEX> (<NUMEX TYPE="PERCENT">45%</NUMEX>), <ENAMEX TYPE="PRODUCT">TNF-1031</ENAMEX> (<NUMEX TYPE="PERCENT">25%</NUMEX>), <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<NUMEX TYPE="CARDINAL">851</NUMEX> (<NUMEX TYPE="PERCENT">15%</NUMEX>)), followed
        by the <ENAMEX TYPE="SUBSTANCE">TNF-308</ENAMEX> (<NUMEX TYPE="PERCENT">11%</NUMEX>) and <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<TIMEX TYPE="DATE">1304</TIMEX> (<NUMEX TYPE="PERCENT">13%</NUMEX>) <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>.
        Interestingly, population-specific recombinant haplotypes
        make the <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX>+<TIMEX TYPE="DATE">1304</TIMEX> SNP more informative in <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>; it is
        required to resolve haplotypes <NUMEX TYPE="CARDINAL">2 and 4 and haplotypes 21</NUMEX>
        and <NUMEX TYPE="CARDINAL">22</NUMEX>, which together make up <NUMEX TYPE="PERCENT">almost 10%</NUMEX> of all the
        <ENAMEX TYPE="ORGANIZATION">haplotypes</ENAMEX>. In <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX> <NUMEX TYPE="CARDINAL">seven</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> must be included to
        represent <NUMEX TYPE="PERCENT">95%</NUMEX> of the <NUMEX TYPE="CARDINAL">12</NUMEX>-SNP haplotypic diversity.
        <ENAMEX TYPE="ORGANIZATION">EMM</ENAMEX> is especially useful when combined with <ENAMEX TYPE="ORGANIZATION">AEA</ENAMEX>. The
        latter can be used to determine how well the recommended
        haplotype-tagging SNPs detect <ENAMEX TYPE="ORG_DESC">association</ENAMEX> at a particular
        <ENAMEX TYPE="ORGANIZATION">candidate SNP</ENAMEX>. The results of <ENAMEX TYPE="ORGANIZATION">AEA</ENAMEX> can then be used to
        adjust the power of an association study accordingly.
        Analysis of the 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> locus in <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="NATIONALITY">African</ENAMEX> <ENAMEX TYPE="PER_DESC">populations</ENAMEX>
        reveals a haplotypically diverse locus where markers are
        only weakly associated with each other. Although initial
        detection of a disease <ENAMEX TYPE="ORG_DESC">association</ENAMEX> in 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> may be difficult, weak allelic
        <ENAMEX TYPE="ORGANIZATION">associations</ENAMEX> within the 
        <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> gene region will make it possible
        to distinguish a disease-modifying SNP from its <ENAMEX TYPE="PER_DESC">neighbors</ENAMEX>.
        Future studies may determine that this is a general feature
        of <ENAMEX TYPE="NATIONALITY">African</ENAMEX> <ENAMEX TYPE="PER_DESC">genomes</ENAMEX>.
      
      
        Materials and methods
        
          Subjects
          Healthy unrelated <ENAMEX TYPE="PER_DESC">adults</ENAMEX> were recruited in <ENAMEX TYPE="GPE">Banjul</ENAMEX>, The
          <ENAMEX TYPE="GPE">Gambia</ENAMEX> and in <ENAMEX TYPE="GPE">Blantyre</ENAMEX>, <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>. All were <ENAMEX TYPE="PER_DESC">parents</ENAMEX> of
          <ENAMEX TYPE="PER_DESC">children</ENAMEX> who presented to <ENAMEX TYPE="ORG_DESC">hospital</ENAMEX> with severe <ENAMEX TYPE="DISEASE">malaria</ENAMEX>.
          All <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> gave informed consent and the study was
          approved by the <ENAMEX TYPE="ORGANIZATION">Gambia Government/Medical Research</ENAMEX>
          <ENAMEX TYPE="ORGANIZATION">Council Joint Ethical Committee</ENAMEX> and the <ENAMEX TYPE="ORGANIZATION">College of</ENAMEX>
          <ENAMEX TYPE="ORGANIZATION">Medicine Research Committee</ENAMEX> of the <ENAMEX TYPE="ORGANIZATION">University of</ENAMEX>
          <ENAMEX TYPE="ORGANIZATION">Malawi</ENAMEX>.
          After excluding erroneous pedigrees, the <NUMEX TYPE="CARDINAL">187</NUMEX>
          parent-child pairs plus <NUMEX TYPE="CARDINAL">45</NUMEX> other <ENAMEX TYPE="PER_DESC">adults</ENAMEX> comprised the
          Gambian sample (a total of <NUMEX TYPE="CARDINAL">212</NUMEX> <ENAMEX TYPE="PER_DESC">adults</ENAMEX>), and <NUMEX TYPE="CARDINAL">70</NUMEX>
          parent-child pairs plus <NUMEX TYPE="CARDINAL">14</NUMEX> other <ENAMEX TYPE="PER_DESC">adults</ENAMEX> (a total of <NUMEX TYPE="CARDINAL">84</NUMEX>
          <ENAMEX TYPE="PER_DESC">adults</ENAMEX>) comprised the <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> sample. We also studied
          <ENAMEX TYPE="SUBSTANCE">DNA</ENAMEX> from <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="ANIMAL">chimpanzees</ENAMEX>, one <ENAMEX TYPE="ANIMAL">gorilla</ENAMEX> and <NUMEX TYPE="CARDINAL">two</NUMEX> orang
          <ENAMEX TYPE="ORGANIZATION">utans</ENAMEX>.
        
        
          SNP identification and genotyping
          In a previous study, we described the nucleotide
          diversity of the 
          <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> locus in <NUMEX TYPE="CARDINAL">36</NUMEX> healthy, unrelated
          Gambian <ENAMEX TYPE="PER_DESC">adults</ENAMEX> [ <TIMEX TYPE="DATE">13</TIMEX> ] . There we identified <NUMEX TYPE="CARDINAL">11</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> by
          forward and reverse sequencing of the entire <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> gene
          from <NUMEX TYPE="PERCENT">-1,389</NUMEX> bp relative to the start of transcription to
          +<NUMEX TYPE="CARDINAL">3,004</NUMEX> bp on <TIMEX TYPE="DATE">72</TIMEX> chromosomes. Here we have genotyped the
          <NUMEX TYPE="CARDINAL">11</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> identified in 
          <ENAMEX TYPE="ORGANIZATION">TNF</ENAMEX> , plus <NUMEX TYPE="CARDINAL">one</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> in the
          neighboring gene, 
          <ENAMEX TYPE="ORGANIZATION">LT</ENAMEX> , in a sample of <NUMEX TYPE="CARDINAL">212</NUMEX> Gambian
          and <NUMEX TYPE="CARDINAL">84</NUMEX> <ENAMEX TYPE="NATIONALITY">Malawian</ENAMEX> <ENAMEX TYPE="PER_DESC">adults</ENAMEX>. The amplification refractory
          mutation system PCR (ARMS-PCR) was used to genotype the
          <ENAMEX TYPE="ORGANIZATION">polymorphisms</ENAMEX> identified by sequencing. Methods are as
          previously described [ <TIMEX TYPE="DATE">13</TIMEX> ] . The accuracy of the
          ARMS-PCR method was tested on sequenced <ENAMEX TYPE="PER_DESC">individuals</ENAMEX>
          before extending it to <ENAMEX TYPE="SUBSTANCE">DNA samples</ENAMEX> of unknown
          <ENAMEX TYPE="ORGANIZATION">genotype</ENAMEX>.
        
        
          Haplotype construction
          For most of these <ENAMEX TYPE="PER_DESC">adults</ENAMEX>, genotypes were available
          from their <ENAMEX TYPE="PER_DESC">children</ENAMEX>, raising the question of how to
          construct haplotypes most efficiently from a dataset
          where pedigree information is available for some but not
          all <ENAMEX TYPE="PER_DESC">individuals</ENAMEX>. We developed a program PHAMILY, which
          uses information from <NUMEX TYPE="CARDINAL">two</NUMEX>-generation pedigrees to
          construct parental haplotypes at all unambiguous sites.
          These partial haplotypes of unambiguous sites serve as
          input for PHASE [ <NUMEX TYPE="CARDINAL">24 25</NUMEX> ] , which uses the
          <ENAMEX TYPE="PERSON">Stephens-Donnelly</ENAMEX> method of haplotype construction to
          assign the remaining phase-unknown sites among the
          unrelated <ENAMEX TYPE="PER_DESC">parents</ENAMEX>. The <NUMEX TYPE="CARDINAL">two</NUMEX> study <ENAMEX TYPE="PER_DESC">populations</ENAMEX> were pooled
          before haplotype construction; after haplotype
          construction, <ENAMEX TYPE="PER_DESC">individuals</ENAMEX> were assigned to their original
          <ENAMEX TYPE="PER_DESC">populations</ENAMEX> on the basis of their sample identifiers.
        
        
          Population genetic analyses
          
            Estimating gene diversity
            An estimate of gene diversity ( 
            <ENAMEX TYPE="ORGANIZATION">H</ENAMEX> ), the probability that two
            randomly chosen haplotypes are different in a sample,
            was calculated using Equation <NUMEX TYPE="MONEY">8.5</NUMEX> from <ENAMEX TYPE="GPE">Nei</ENAMEX> [ <TIMEX TYPE="DATE">26</TIMEX> ] ,
            
            where 
            <ENAMEX TYPE="ORGANIZATION">n</ENAMEX> is the number of gene copies in
            the sample, 
            <ENAMEX TYPE="ORGANIZATION">k</ENAMEX> is the number of different
            haplotypes, and 
            p 
            
              i 
             is the frequency of the 
            i th haplotype. The sampling
            variance of this estimate was calculated according to
            <ENAMEX TYPE="ORGANIZATION">Nei</ENAMEX> and <ENAMEX TYPE="ORGANIZATION">Roychoudhury</ENAMEX> [ <TIMEX TYPE="DATE">27</TIMEX> ] . The computer software
            Arlequin was used to perform these calculations [ <NUMEX TYPE="CARDINAL">28 29</NUMEX>
            ] .
          
          
            Construction of haplotype networks
            Network2.oc was used to construct median-joining
            <ENAMEX TYPE="ORG_DESC">networks</ENAMEX> of the haplotypic data [ <TIMEX TYPE="DATE">30</TIMEX> ] . Because of the
            occurrence of many low-frequency recombinant haplotypes
            in the dataset, only haplotypes observed <NUMEX TYPE="CARDINAL">twice</NUMEX> or more
            were represented in the <ENAMEX TYPE="ORG_DESC">network</ENAMEX>. Output from
            Network2.oc was critically evaluated and some
            modifications made to best fit a model of minimum
            mutation.
          
          
            <NUMEX TYPE="CARDINAL">Four</NUMEX>-gamete test
            <NUMEX TYPE="CARDINAL">All</NUMEX> pairs of biallelic <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> were cross-tabulated to
            identify the number of unique <NUMEX TYPE="CARDINAL">two</NUMEX>-locus haplotypes
            present. An observation of <NUMEX TYPE="CARDINAL">four</NUMEX> different haplotypes
            from a pair of biallelic loci was considered evidence
            for recombination or recurrent mutation.
          
          
            <ENAMEX TYPE="PER_DESC">Population differentiation</ENAMEX> and pairwise F
            <ENAMEX TYPE="ORGANIZATION">ST</ENAMEX>
            Pairwise 
            F 
            
              <ENAMEX TYPE="ORGANIZATION">ST</ENAMEX> 
             was calculated as the genetic variance among
            <ENAMEX TYPE="PER_DESC">populations</ENAMEX> divided by the genetic variance of the
            total <ENAMEX TYPE="PER_DESC">population</ENAMEX> using haplotypic data [ <TIMEX TYPE="DATE">31</TIMEX> ] . An
            exact test of population differentiation was applied to
            the haplotypic data [ <TIMEX TYPE="DATE">32</TIMEX> ] . The computer software
            Arlequin was used to perform these calculations [ <NUMEX TYPE="CARDINAL">28 29</NUMEX>
            ] .
          
          
            Linkage disequilibrium calculations
            Pairwise linkage disequilibria were calculated using
            the 
            r <TIMEX TYPE="DATE">2statistic</TIMEX>. Terms for allele
            and <NUMEX TYPE="CARDINAL">two</NUMEX>-locus haplotype frequencies are given in Table
            <NUMEX TYPE="CARDINAL">3</NUMEX>. 
            r 2was calculated using
            
            where 
            D =  
            <NUMEX TYPE="CARDINAL">11</NUMEX>  
            <NUMEX TYPE="CARDINAL">22</NUMEX> -  
            <NUMEX TYPE="CARDINAL">12</NUMEX>  
            <TIMEX TYPE="DATE">21</TIMEX> . Normalized linkage
            disequilibrium parameters 
            D ' were calculated using the
            method of <ENAMEX TYPE="ORGANIZATION">Lewontin</ENAMEX> [ <TIMEX TYPE="DATE">33</TIMEX> ] in <ENAMEX TYPE="GPE">Hartl</ENAMEX> and <ENAMEX TYPE="PERSON">Clark</ENAMEX> [ <TIMEX TYPE="DATE">34</TIMEX> ] .
            Statistical significance of the standardized linkage
            disequilibrium parameter was calculated using the
            formula
            
            with one degree of freedom [ <TIMEX TYPE="DATE">34</TIMEX> ] , where 
            <ENAMEX TYPE="ORGANIZATION">N</ENAMEX> is the number of
            chromosomes.
          
        
        
          <ENAMEX TYPE="ORGANIZATION">Association</ENAMEX> efficiency analysis (AEA)
          To assess the ability of <NUMEX TYPE="CARDINAL">one</NUMEX> marker to detect a given
          disease <ENAMEX TYPE="ORG_DESC">association</ENAMEX> at <TIMEX TYPE="TIME">a second marker</TIMEX>, we derived a
          measure we call association efficiency, which is the
          relative risk at <NUMEX TYPE="CARDINAL">one</NUMEX> <ENAMEX TYPE="ORGANIZATION">SNP</ENAMEX> by virtue of its association
          with a <NUMEX TYPE="ORDINAL">second</NUMEX> SNP. Consider a disease-modifying SNP 
          A that is in linkage disequilibrium
          with a neighboring nonfunctional SNP 
          B . We define 
          R 
          
            A 
           as the relative risk associated with allele 
          A 
          <NUMEX TYPE="CARDINAL">2</NUMEX> compared to allele 
          A 
          <NUMEX TYPE="CARDINAL">1</NUMEX> . Under a multiplicative mode of
          <ENAMEX TYPE="PERSON">inheritance</ENAMEX>, the frequencies of the different haplotypes
          (A 
          <NUMEX TYPE="CARDINAL">1</NUMEX> , A 
          <TIMEX TYPE="DATE">1</TIMEX> B 
          <NUMEX TYPE="CARDINAL">2</NUMEX> , A 
          <TIMEX TYPE="DATE">2</TIMEX> B 
          <NUMEX TYPE="CARDINAL">1</NUMEX> , A 
          <TIMEX TYPE="DATE">2</TIMEX> B 
          <NUMEX TYPE="CARDINAL">2</NUMEX> ) found in diseased <ENAMEX TYPE="PER_DESC">individuals</ENAMEX> is
          expected to be  
          <TIMEX TYPE="DATE">11</TIMEX> ,  
          <TIMEX TYPE="DATE">12</TIMEX> , 
          R 
          
            A 
            
          <TIMEX TYPE="DATE">21</TIMEX> , and 
          R 
          
            A 
            
          <TIMEX TYPE="DATE">22</TIMEX> (see <ENAMEX TYPE="PRODUCT">Table 3</ENAMEX>). Given the risk
          <ENAMEX TYPE="ORGANIZATION">associated</ENAMEX> with 
          A 
          <NUMEX TYPE="CARDINAL">2</NUMEX> and the frequency of each haplotype,
          we can derive the frequency of allele 
          B 
          <NUMEX TYPE="CARDINAL">2</NUMEX> among diseased <ENAMEX TYPE="PER_DESC">individuals</ENAMEX> ( 
          q 
          <ENAMEX TYPE="PRODUCT">2</ENAMEX> ').
          
          The frequency of allele 
          B 
          <NUMEX TYPE="CARDINAL">2</NUMEX> in the general <ENAMEX TYPE="PER_DESC">population</ENAMEX> is defined
          as 
          q 
          <NUMEX TYPE="CARDINAL">2</NUMEX> . Thus, in a case-control study
          where diseased <ENAMEX TYPE="PER_DESC">individuals</ENAMEX> are compared to <ENAMEX TYPE="PER_DESC">individuals</ENAMEX>
          drawn from the general <ENAMEX TYPE="PER_DESC">population</ENAMEX>, we would obtain an
          odds ratio for allele 
          B 
          <NUMEX TYPE="CARDINAL">2</NUMEX> of
          
          This odds ratio provides an approximation of the
          relative risk that is associated with the non-functional
          allele 
          B 
          <NUMEX TYPE="CARDINAL">2</NUMEX> by virtue of its association with
          the disease allele 
          A 
          <NUMEX TYPE="CARDINAL">2</NUMEX> .
          When locus B is considered to be the disease-modifying
          locus, with 
          R 
          
            B 
           as the relative risk associated with allele 
          B 
          <NUMEX TYPE="CARDINAL">2</NUMEX> compared to 
          B 
          <NUMEX TYPE="CARDINAL">1</NUMEX> , it can be shown that the relative
          risk at locus 
          A is
          
          In this <ENAMEX TYPE="ORG_DESC">paper</ENAMEX>, we consider the possibility that the
          rarer allele gives a true relative risk of <NUMEX TYPE="MONEY">10</NUMEX> for a given
          <ENAMEX TYPE="DISEASE">disease</ENAMEX>, and calculate the apparent relative risk at all
          other loci. We do this for all pairs of loci. Because
          this property does not commute (that is, the apparent
          relative risk at locus 
          B given a true relative risk of <NUMEX TYPE="CARDINAL">10</NUMEX>
          at locus 
          A is not necessarily equal to the
          apparent relative risk at locus 
          A given a true relative risk of <NUMEX TYPE="CARDINAL">10</NUMEX>
          at locus 
          B ) we calculate <NUMEX TYPE="CARDINAL">two</NUMEX> values for
          each pair of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>.
        
        
          Entropy maximization method (EMM)
          A measure of haplotypic diversity, entropy ( 
          E ), was calculated using
          
          where 
          p 
          
            i 
           is the frequency of the 
          i th haplotype, and 
          <ENAMEX TYPE="ORGANIZATION">k</ENAMEX> is the number of unique
          <ENAMEX TYPE="ORGANIZATION">haplotypes</ENAMEX> in the sample. <ENAMEX TYPE="ORGANIZATION">Entropy</ENAMEX> is maximized when all
          haplotypes have the same frequency. We developed an
          algorithim that chooses <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX>, first individually, then in
          <ENAMEX TYPE="ORGANIZATION">multi-SNP</ENAMEX> haplotypes, that maximize <ENAMEX TYPE="PER_DESC">entropy</ENAMEX> [ <TIMEX TYPE="DATE">35</TIMEX> ] . Thus
          we can define a subset of <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> that represent the
          greatest proportion of the full <NUMEX TYPE="CARDINAL">12</NUMEX>-SNP haplotypic
          diversity. This method provides for the selection of
          optimal haplotype-tagging <ENAMEX TYPE="ORGANIZATION">SNPs</ENAMEX> even in the absence of a
          clear haplotypic <ENAMEX TYPE="FAC_DESC">block structure</ENAMEX>.
        
      
      
        Additional data files
        A g-zipped file of the C source code for the program (
        Additional data file <NUMEX TYPE="CARDINAL">1</NUMEX>) together with instructions for
        compiling the C source code ( Additional data file <NUMEX TYPE="CARDINAL">2</NUMEX>) are
        available. Instructions for how to run the compile program
        ( Additional data file <NUMEX TYPE="CARDINAL">3</NUMEX>), an example output file with an
        introduction ( Additional data file <NUMEX TYPE="CARDINAL">4</NUMEX>) and an example of
        the input file format ( Additional data file <NUMEX TYPE="CARDINAL">5</NUMEX>), as well as
        a file listing marker selection by maximum entropy <TIMEX TYPE="DATE">94kb</TIMEX> (
        Additional data file <NUMEX TYPE="CARDINAL">6</NUMEX>) can also be downloaded. The
        <ENAMEX TYPE="ORGANIZATION">algorithm</ENAMEX> is also available from [ <TIMEX TYPE="DATE">35</TIMEX> ] .
        Additional data file 1
        A g-zipped file of the C source code for the program
        A g-zipped file of the C source code for the program
        Click here for additional data file
        Additional data file 2
        Instructions for compiling the C source code
        Instructions for compiling the C source code
        Click here for additional data file
        Additional data file 3
        Instructions on how to run the compiled program
        Instructions on how to run the compiled program
        Click here for additional data file
        Additional data file 4
        An example output file with an introduction
        An example output file with an introduction
        Click here for additional data file
        Additional data file 5
        An example of the input file format
        An example of the input file format
        Click here for additional data file
        Additional data file 6
        A mathematical explanation of the method
        A mathematical explanation of the method
        Click here for additional data file
      
    
  
